Follow The Filings

CLPT ClearPoint Neuro

ClearPoint Neuro earnings company data as of 4:45 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by CLPT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CLPT insider trades
  • None no insider bought on the open market
  • $185K sold by 1 insider outside a trading plan
  • $2.2M sold by 1 insider under 10b5-1 plans
  1. Joseph Burnett CEO
    Planned sale
    $388K 20,000 shares at $19.38 15% of stake
    Traded Jun 29 Filed Jul 1
  2. Joseph Burnett CEO
    Planned sale
    $1.1M 61,843 shares at $17.79
    Traded Jun 17 Filed Jun 22
  3. Matthew B. Klein Director
    Sale
    $185K 16,000 shares at $11.59 25% of stake
    Traded May 21 Filed May 26
  4. Joseph Burnett CEO
    Planned sale
    $303K 19,951 shares at $15.17 9.4% of stake
    Traded Feb 25 Filed Feb 26
  5. Joseph Burnett CEO
    Planned sale
    $46K 2,943 shares at $15.57 1.4% of stake
    Traded Jan 26 Filed Jan 27
  6. Joseph Burnett CEO
    Planned sale
    $322K 20,000 shares at $16.12 63% of stake
    Traded Jan 9 Filed Jan 13
  7. Joseph Burnett CEO
    Planned sale
    $714K 26,463 shares at $26.98 11% of stake
    Traded Oct 10, 2025 Filed Oct 14, 2025

Also filed in the last 12 months, not counted as buying or selling: 28 option exercises, 17 stock grants, 15 share withholdings for taxes, and 2 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G/A —
8-K 5.02,5.07,9.01
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
10-Q
DEFA14A
SCHEDULE 13G/A —
DEF 14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.